scholarly article | Q13442814 |
P50 | author | Iscia Lopes-Cendes | Q42419183 |
P2093 | author name string | Andermann F | |
Dubeau F | |||
Andermann E | |||
Benjamin A | |||
Duncan S | |||
Seni MH | |||
Mercho S | |||
P2860 | cites work | Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation | Q29615365 |
Neural-tube defects and derangement of homocysteine metabolism | Q44703867 | ||
P433 | issue | 6 | |
P304 | page(s) | 750-753 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Epilepsia | Q5382969 |
P1476 | title | Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality | |
P478 | volume | 42 |
Q35095179 | Anti-epileptic drugs in pregnancy: current safety and other issues |
Q36292532 | Birth defects after prenatal exposure to antiepileptic drugs |
Q36511300 | Birth defects and epilepsy medication |
Q35147180 | Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation |
Q36697463 | Currently available antiepileptic drugs |
Q37486720 | Epilepsy pharmacogenetics |
Q37426143 | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology |
Q31046235 | Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. |
Q34309022 | Gene–environment interactions, folate metabolism and the embryonic nervous system |
Q34722379 | Management of epilepsy during pregnancy |
Q36370360 | Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid |
Q80374303 | Neuropsychological outcomes in children of mothers with epilepsy |
Q44880512 | Oxcarbazepine in pregnancy: clinical experience in Argentina |
Q56449619 | Perinatal outcomes from the use of antiepileptic drugs during pregnancy: a case-control study |
Q37869124 | Pharmacogenetics of drug-induced birth defects: what is known so far? |
Q35236942 | Pregnancy, epilepsy, and anticonvulsants. |
Q34910353 | Prevalence and Correlates of Neural Tube Defect in South West Iran: Retrospective analysis. |
Q36235506 | Safety of antiepileptic drugs during pregnancy |
Q43737555 | Teratogenesis in repeated pregnancies in antiepileptic drug-treated women |
Q37301544 | Teratogenicity and antiepileptic drugs: potential mechanisms |
Q37262946 | Teratogenicity of antiepileptic medications |
Q36082034 | Teratogenicity of sodium valproate |
Q36603158 | Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? |
Q36373816 | Update on pharmacogenetics in epilepsy: a brief review. |
Q36729620 | Various pharmacogenetic aspects of antiepileptic drug therapy: a review |